1 / 26

Quality Assurance Puritan Bennett 840: Hazards/ Warnings/ Recalls

Quality Assurance Puritan Bennett 840: Hazards/ Warnings/ Recalls. Olina D’Souza (BSc., SRT), Kineta Snyder (SRT) Dalhousie School of Health Sciences – Respiratory Therapy. Objectives. Describe the methods used to research. Define quality assurance (QA) . Describe the warnings.

abram
Download Presentation

Quality Assurance Puritan Bennett 840: Hazards/ Warnings/ Recalls

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Quality Assurance Puritan Bennett 840:Hazards/ Warnings/ Recalls Olina D’Souza (BSc., SRT), Kineta Snyder (SRT) Dalhousie School of Health Sciences – Respiratory Therapy

  2. Objectives • Describe the methods used to research. • Define quality assurance (QA). • Describe the warnings. • Describe the hazards. • Describe how the RRT and Covidien tracks issues related to the PB 840.

  3. Methods used to research • Emergency care research institute (ECRI) • Food and Drug administration (FDA) • Pubmed • Covidien • Biomedical Department

  4. Quality Assurance • The international standards organization defines QA as: • Guidelines that can be used consistently to ensure materials, products, processes and services designed for specific purposes are fulfilled

  5. History • PB 840 was introduced in 1998. • What is the process of ventilator launch? • Requirements set by design control need to be met in a pre-launch phase – i.e. trouble shooting the ventilator for worse case scenarios, patient stimulation • Once standards have been met in the pre-launch phase the ventilator is used in the post launch world – i.e hospital, ambulance, home-care environment

  6. Manufacturer upgrades

  7. PB 840 Software • If a newer version of the PB840 software has been released, do all ventilators needs to be upgraded? • Changes made to software are not mandatory. Facilities and depending on government regulations dictate if a newer software needs to be installed.

  8. Patient Warnings • Audio • Visual • Do NOT press the alarm silence button and leave patient unattended

  9. Warnings: PB 840 set-up • Connect air source to air intake and oxygen source to oxygen intake • 2 gasses must be connected at all times • Connections to the ventilator must be clean, unlubricated and no water present in the air/oxygen supply gas

  10. Warnings: PB 840 • Use of low resistance circuits – high resistance circuits may not prevent ventilation but cause an SST fault and/or decrease patient’s ability to breathe through the circuit • Also, ensures optimal compliance compensation • Shock hazard – PB840 must be electrically connected to a grounded AC outlet

  11. Manufactures recommendations • The manufacturer provides specific recommendations related to the PB840 that clinicians are responsible for in order to ensure high QA. • What are regulations surrounding how often checks need to be run on the PB 840? • Manufacturer has obligation to provide details on the frequency of checks that should be run on PB840 to ensure the device is running properly.

  12. Operational Hazard

  13. Operational Hazards • December 2012 and Novemeber 2012- The customer reported that the 840 ventilator had a blank screen while in use on a patient. The patient was not harmed or injured as a result of the event. Covidienfigured out the problem with the customer over the phone. The customer was advised to replace the graphical interface unit (gui) cable.

  14. Operational Hazards – Local Issues • Recent problems with new Hudson RCI made by Teleflex medical circuit. • Connection seal between circuit and ventilator may cause the PB 840 to not pass the SST.

  15. Electromagnetic Interference (EMI) • Yes, that means cell phones!! • The manufacturer has identified four facilities in which the 840 ventilator stopped breath delivery and entered a safety-valve-open state on a patient. • Manufacture found that cell phones can created a disturbance when placed within a meter (3 ft) of the 840’s breath-delivery unit

  16. Patient Hazards • Incorrect patient circuit type and humidification entered (when performing an SST, EST) will affect patient compliance, VT(exhaled)calculated • FIX: Rerun the test with correct circuit and humidification used

  17. Patient Hazards • Disconnect patient from the ventilator before running SST • Do not repeat an individual test with a different patient circuit if the SST result is ‘failure’ or ‘alert’ • FIX: Restart SST from the beginning and ensure SST has been successfully completed

  18. Recalls

  19. Capital District Health Authority (CDHA) - Reporting

  20. CDHA reporting

  21. CDHA - Reporting

  22. Covidien: Q & A • What types of questions are asked by Covidien when an issue with the ventilator (i.e. PB840) does arise? • Type of failure occurred ? Negative outcome to patient/ patients? Is this a one time issue or a recurrence? Is there a negative shift?

  23. Covidien: Q & A • How is a malfunctioned ventilator component tracked? • Many of the parts on a ventilator are serialized. If a part has malfunctioned and is sent to be repaired it is tracked via the serial number on the device. • How are records maintained? • Records are maintained in a database (i.e. FDA) that is publicly accessibly.

  24. Summary • Ensuring quality assurance is an essential component in the practice of Respiratory Care. • Questions about issues/ failures with equipment should be documented and reported in an effective manner to minimize personal and patient harm. • Issues with quality assurance may be found through the FDA, ECRI and company website. • Reports used in this quality assurance presentation were localized to the Capital Health District Authority, Halifax, Nova Scotia, Canada.

More Related